2022
DOI: 10.1016/j.tipsro.2022.07.001
|View full text |Cite
|
Sign up to set email alerts
|

Reduction of oesophageal toxicity with VMAT dose-sparing radiotherapy in thoracic metastatic spinal cord compression: A feasibility study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 29 publications
0
0
0
Order By: Relevance
“…Remberg Gram and co-workers demonstrated the feasibility of VMAT in sparing the esophagus in a planning study on 29 pts with metastatic spinal cord compression (MSCC) [30]. In an ongoing clinical trial, a prospective cohort of 65 pts with MSCC is being treated with VMAT (or SBRT in pts with single spinal metastases) with 18 × 2.33 Gy [31].…”
Section: Discussionmentioning
confidence: 99%
“…Remberg Gram and co-workers demonstrated the feasibility of VMAT in sparing the esophagus in a planning study on 29 pts with metastatic spinal cord compression (MSCC) [30]. In an ongoing clinical trial, a prospective cohort of 65 pts with MSCC is being treated with VMAT (or SBRT in pts with single spinal metastases) with 18 × 2.33 Gy [31].…”
Section: Discussionmentioning
confidence: 99%